Format

Send to

Choose Destination
Clin Imaging. 2016 Jul-Aug;40(4):601-9. doi: 10.1016/j.clinimag.2016.02.011. Epub 2016 Feb 16.

Magnetic resonance imaging of prostate cancer.

Author information

1
Department of Radiology, Bulent Ecevit University of Medicine, Zonguldak, Turkey. Electronic address: drserkanguneyli@gmail.com.
2
Department of Radiology, Bulent Ecevit University of Medicine, Zonguldak, Turkey.

Abstract

Prostate cancer is one of the causes of cancer-related deaths. Multiparametric magnetic resonance imaging (MRI) provides the best soft tissue resolution and plays an important role in the management of prostate cancer patients. It is the recommended imaging modality for patients with prostate cancer, and it is clinically indicated for diagnosis, staging, tumor localization, detection of tumor aggressiveness, follow-up, and MRI-guided interventions. Multiparametric MRI includes T1- and high-resolution T2-weighted imaging, diffusion-weighted imaging, and dynamic contrast-enhanced MRI. We evaluated MR images of patients with prostate cancer who underwent multiparametric endorectal MRI on a 3.0-T scanner and presented demonstrative images.

KEYWORDS:

Cancer; Magnetic resonance imaging; Multiparametric; Prostate

PMID:
27317204
DOI:
10.1016/j.clinimag.2016.02.011
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center